Full-stack clinician and engineer | improving front-end patient care through back-end biomedicine, data science, and tech

Cambridge, UK
Joined November 2018
When I was choosing my training programme, one thing mattered to me: would I be working with electronic patient records and electronic prescribing? These are the tools you use every day. I wanted to know what I’d be working with before choosing where to go.
1
1
89
The data is a work in progress. Some entries come from trust-level sources rather than individual hospital confirmation, so the evidence and its limitations matter.
1
24
Explore the map: ehr-map.finomics.app/ When you were choosing where to work, did the hospital’s IT systems influence your decision?
28
Why can't doctors decide when they can work? We're building self-rostering to be free, for all, forever. Pick shifts. Build a draft. See the gaps. Early access: cloud.finomics.app/beta
1
64
If you organise a rota and want help trying this with your team, comment below or message me. What’s the biggest obstacle to letting doctors choose their shifts?
11
Built a few key features into sync over the weekend with the help from GPT sol 5.6 - Integrated chat function for organising socials - Shift swapper to get the annual leave you want - Payslip verification with rota to track income Try it out at sync.finomics.app/beta
140
Over a year ago, a call with @ravi_sola changed my life. Since then, I’ve watched how @PrimaMente grow with speed, creativity, rigour, and relentless drive, pushing deep tech into clinical applications. It’s been inspiring to witness, and even better to be part of.
1/ Today we announce Pleiades, a series of epigenetic foundation models (90M→7B params) trained on 1.9T tokens of human methylation & genomic data. Pleiades accurately models epigenetics for genomic track prediction, generation & neurodegenerative disease detection from cfDNA, outperforming previous pure DNA baselines.
5
235
Over the coming weeks, we will be introducing Prima Mente to the world. We kicked off today at @NVIDIAGTC Paris highlighting two foundational collaborations: @nebiusai has become a core partner for our work to generate the world’s largest brain foundation models. Our goal long-term: understand the brain across health, age, and disease. Through @nvidia DGX Cloud with Lepton, we have started to scale our exciting work in Alzheimer’s Disease to Parkinson’s. Thank you to Arkady Volozh and Jensen Huang for supporting what will be the biggest application of AI in our world today - human health. It is a privilege to work with both the @nvidia (Janisha Anand, @cedricSteenb, Ben Griffiths) and @nebiusai (@romanchernin, Danila Shtan, Ilya Burkov, Hasan Göktuğ Çolak, Anastasia Ustinova) teams. Links to both press releases are in the thread.
1
4
1
11
1,933
🚨 We’re #hiring a Staff Scientist to drive innovative computational workflows for large-scale, multi-omics data in human microbiome research @LawleyLab @sangerinstitute 📅 Closing date: 27th April 2025 📢 Please share & apply! sanger.wd103.myworkdayjobs.c…
6
13
1,091
How should we evaluate #LLMs for downstream clinical use cases? In this @npjDigitalMed article, we propose a transition from static QA-style benchmarks to dynamic agent-based simulators, similar to methods used in biology, epidemiology & social sciences. nature.com/articles/s41746-0…
1
27
1
69
9,925
Congratulations to my student @tenghiangh on her first PhD preprint! It's about recessive associations in @GenesHealth , a cohort of >40k British South Asians. See her thread for an account and the paper here medrxiv.org/content/10.1101/….
When we think of recessive conditions, rare monogenic disorders come to mind. Yet variants have recessive effects on common diseases too! We profiled the single-variant recessive landscape of a cohort of 44k British South Asians, now live on medRxiv: (1/11)
8
36
3,189
Our paper describing a way to infer the phase of rare variant pairs using gnomAD v2 is out now in Nature Genetics. We hope that the resource we generated will be useful when interpreting rare co-occurring variants in the context of recessive disease. nature.com/articles/s41588-0…
4
73
9
243
42,113
So brilliant that @DrXiaoLiu @sktywagner could showcase for @RishiSunak our work on #oculomics #FoundationModels #RETFound and #Equity #Safety of AI-enabled Healthcare Proud UK can be a leader in Artificial Medical Intelligence 🇬🇧🇬🇧 @Moorfields @UCLeye @uhbtrust @unibirmingham
Replying to @RishiSunak
@RishiSunak was @Moorfields this morning, for a live demo from @sktywagner and @DrXiaoLiu of how INSIGHT is enabling world-leading research using AI to detect disease from retinal scans. @UCLeye @uhbtrust msn.com/en-gb/travel/news/ri…
3
15
67
5,076
MTF is excited to announce we will be delivering a talk as part of Ipswich Hospital's Basic and Laproscopic Surgical Skills Course. The event is free to attend and will be in person at Ipswich Hospital on October 13th. Hope to see you there!
2
4
5
975
Is anyone here using the UKBiobank 200k genomes dataset? We are having some weird issues and are trying to troubleshoot if data vs code 😬 Anyone else seeing anything odd? Either way, please share! 🧬
2
6
9
5,484
Great lineup for the inaugural webinar from the Consortium for Vision and Oculomics in Psychiatry @CVOPorg
🌟Exciting news! 🧠👁 Join CVOP's inaugural webinar, "From Eye to Brain: Oculomics and Schizophrenia"! 🚀 Register now at cvop.org/fromeyetobrain to dive into the fascinating world where #Psychiatry and #VisionScience intersect. #AcademicTwitter #ScienceCommunity
2
3
10
1,241
Many congratulations @sktywagner! Very well deserved and thank you so much for all the wisdom imparted. Real stars bring lights to others and you have never stopped doing that. 🎉
👏Congratulations to @sktywagner - one of ten rising stars on @OphthoMag's 2023 Power List. Siegfried is a core member of the research group supported by INSIGHT in advancing the field of #oculomics @Moorfields @UCLeye @MoorfieldsBRC 🔗Read more: bit.ly/45jYLQL
1
8
925
Congratulations @sktywagner! 🥳🤩Speaking for the whole group when I say we are incredibly proud of the many feats you’ve achieved this year and excited for the way your work and #AlzEye will propel #oculomics ! A #risingstar indeed @OphthoMag 👏🏽
👏Congratulations to @sktywagner - one of ten rising stars on @OphthoMag's 2023 Power List. Siegfried is a core member of the research group supported by INSIGHT in advancing the field of #oculomics @Moorfields @UCLeye @MoorfieldsBRC 🔗Read more: bit.ly/45jYLQL
1
3
25
2,190